Discontinued — last reported Q4 '25
Operating Expenses
Impairment Charges
This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ4 2025Feb 13, 2026
How to read this metric
An increase signals potential issues with asset quality, failed projects, or overly optimistic past valuations.
Detailed definition
Impairment charges represent the write-down of the carrying value of non-goodwill assets when their fair value falls bel...
Peer comparison
Standard accounting adjustment; high frequency or magnitude often triggers investor scrutiny regarding management's capital allocation.
Metric ID:
impairment_chargesHistorical Data
12 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $379M | $0 | $0 | $0 |
| QoQ Change | — | — | — | — | — | — | — | — | — | -100.0% | — | — |
Range$0 – $379M
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Pharmaceuticals | $379M | $0 | $0 | $0 | $0 |
| Total | $379M | $0 | $0 | $0 | — |
Impairment Charges at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's impairment charges?
- Vertex Pharmaceuticals (VRTX) reported impairment charges of $0 in Q4 2025.
- What does impairment charges mean?
- A non-cash expense recorded when an asset's value drops significantly below its recorded book value.